Last reviewed · How we verify
Placebo Inhalation Powder Diskus — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo Inhalation Powder Diskus (Placebo Inhalation Powder Diskus) — GlaxoSmithKline. Placebo has no active pharmacological mechanism; it is an inert substance used as a control in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo Inhalation Powder Diskus TARGET | Placebo Inhalation Powder Diskus | GlaxoSmithKline | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo Inhalation Powder Diskus CI watch — RSS
- Placebo Inhalation Powder Diskus CI watch — Atom
- Placebo Inhalation Powder Diskus CI watch — JSON
- Placebo Inhalation Powder Diskus alone — RSS
Cite this brief
Drug Landscape (2026). Placebo Inhalation Powder Diskus — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-inhalation-powder-diskus. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab